ReviewMedicina (Kaunas, Lithuania)2021

Clinical Effectiveness of Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer with a Poor Performance Status.

Kyoichi Kaira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.